Medicare Enrolled

Dr. Sean Kearin, MD

Hematology · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
8725 N WICKHAM RD STE 202, Melbourne, FL 32940
3212684200
In practice since 2008 (17 years)
NPI: 1457511941 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kearin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kearin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kearin

Dr. Sean Kearin is a hematology in Melbourne, FL, with 17 years in practice. Based on federal Medicare data, Dr. Kearin performed 86,766 Medicare services across 2,122 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kearin received a total of $404 from 14 pharmaceutical and/or device companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kearin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 49% volume in FL$ $404 industry payments

Medicare Practice Summary

Medicare Utilization ↗
86,766
Medicare services
Top 49% in FL for hematology
2,122
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,104 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)23,250$1$3
Iron infusion (Feraheme)19,890$0$3
Pembrolizumab injection (Keytruda)14,400$43$106
Denosumab injection (Prolia/Xgeva)8,820$18$45
Iron sucrose injection (Venofer)6,400$0$1
Anti-nausea injection (fosaprepitant)4,950$0$4
Epoetin alfa injection (Retacrit) for anemia3,000$6$21
Dexamethasone injection (steroid)742$0$0
Office visit, established patient (20-29 min)601$65$180
Anti-nausea injection (ondansetron/Zofran)572$0$1
Office visit, established patient (30-39 min)492$95$255
Anti-nausea injection (Aloxi/palonosetron)430$1$31
Office visit, established patient, complex (40-54 min)376$129$359
Drug injection, under skin or into muscle315$10$42
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less289$48$134
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less216$22$57
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle216$54$143
Administration of chemotherapy into vein, 1 hour or less215$95$257
Injection, magnesium sulfate, per 500 mg189$1$2
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour183$15$40
Leuprolide acetate (for depot suspension), 7.5 mg172$136$1,093
Injection, diphenhydramine hcl, up to 50 mg117$1$3
Injection of additional new drug or substance into vein101$12$37
Irrigation of implanted venous access drug delivery device89$16$50
Initial hospital admission, high complexity87$130$362
Administration of chemotherapy into vein, each additional hour82$21$56
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle55$24$66
Collection of blood sample from implanted device48$18$52
Hospital follow-up visit, high complexity47$91$234
New patient office visit, complex (60-74 min)46$173$443
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session44$257$692
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg44$1$5
Infusion, normal saline solution , 1000 cc40$2$6
Drawing of blood for a medical problem37$63$192
Infusion into a vein for hydration, 31-60 minutes34$22$96
Administration of additional new drug or substance into vein, 1 hour or less34$47$126
Hospital follow-up visit, moderate complexity31$57$154
Transfusion of blood or blood products27$30$76
Red blood cells, leukocytes reduced, each unit26$47$564
New patient office visit (45-59 min)21$111$335
Infusion into a vein for hydration, each additional hour14$9$25
Initial hospital admission, moderate complexity12$103$266
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev12$176$453
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.6% high complexity
46.9% medium
2.5% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$404
Total received (2018-2023)
Avg $67/year across 6 years
Bottom 9% in FL for hematology
14
Companies
24
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$315 (77.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89 (22.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$21
2022
$120
2021
$19
2020
$77
2019
$156
2018
$11

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$79
Janssen Biotech, Inc.
$56
Novartis Pharmaceuticals Corporation
$49
Merck Sharp & Dohme Corporation
$38
GENZYME CORPORATION
$33
Incyte Corporation
$27
Mirati Therapeutics, Inc.
$21
Seagen Inc.
$19
PFIZER INC.
$17
E.R. Squibb & Sons, L.L.C.
$15
AstraZeneca Pharmaceuticals LP
$15
Genentech USA, Inc.
$12
Pharmacyclics LLC, An AbbVie Company
$12
Clovis Oncology, Inc.
$11
Top 3 companies account for 45.7% of total payments
Associated products mentioned in payments ›
CALQUENCE · DARZALEX · IBRANCE · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KRAZATI · LYNPARZA · Neulasta · OPDIVO · PADCEV · PIQRAY · Perjeta · RYBREVANT · Rubraca
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $0 per 100 Medicare services performed
Looking for a hematology in Melbourne?
Compare hematologys in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
10
Per 100K population
1.6
County median income
$75,817
Nearest hospital
VIERA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kearin is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kearin experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Kearin performed 23,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kearin receive payments from pharmaceutical companies?
Yes. Dr. Kearin received a total of $404 from 14 companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kearin's costs compare to other hematologys in Melbourne?
Dr. Kearin's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kearin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →